<?xml-stylesheet type="text/xsl" href="https://emersonexchange365.com/cfs-file/__key/system/syndication/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>ASTM E2500-Early, Targeted Testing Leads to Faster&amp;#160;Implementations</title><link>/industries/lifesciences/b/life-sciences-blog/posts/astm-e2500-early-targeted-testing-leads-to-faster-160-implementations</link><description>Last week, I highlighted Emerson’s Heather Schwalje thoughts on Continuous Process Verification per U.S. Food &amp;amp; Drug Administration (FDA) guidelines. In a comment, Pharmaceutical Manufacturing magazine senior editor, Paul Thomas, highlighted a great article</description><dc:language>en-US</dc:language><generator>Telligent Community 13</generator></channel></rss>